Prajna Generics Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 08-07-2024
- Paid Up Capital ₹ 0.10 M
as on 08-07-2024
- Company Age 10 Year, 1 Month
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 10.00 M
as on 08-07-2024
- Revenue 3.34%
(FY 2022)
- Profit -16.27%
(FY 2022)
- Ebitda 103.93%
(FY 2022)
- Net Worth 65.73%
(FY 2022)
- Total Assets -2.56%
(FY 2022)
About Prajna Generics
The Company is engaged in the Chemicals And Resources Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 Cr.
Maddula Lakshmi, Srinivasula Maddula, and Obula Indela serve as directors at the Company.
- CIN/LLPIN
U24233TG2014PTC095294
- Company No.
095294
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Aug 2014
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
K.V.Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Prajna Generics Private Limited offer?
Prajna Generics Private Limited offers a wide range of products and services, including Insecticides and Pesticides, Fungicides, Termiticide.
Who are the key members and board of directors at Prajna Generics?
Board Members(3)
Financial Performance and Corporate Structure Insights of Prajna Generics.
Prajna Generics Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 3.34% increase. The company also saw a substantial fall in profitability, with a 16.27% decrease in profit. The company's net worth Soared by an impressive increase of 65.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prajna Generics?
In 2021, Prajna Generics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Prajna Biologix Private Limited
Active
2 years 4 months Maddula Lakshmi and Srinivasula Maddula are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 15 Dec 2021 | ₹1.00 Cr | Open |
How Many Employees Work at Prajna Generics?
Prajna Generics has a workforce of 26 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prajna Generics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prajna Generics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
